Louis Verret

618 total citations
26 papers, 415 citations indexed

About

Louis Verret is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Louis Verret has authored 26 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 12 papers in Physiology and 9 papers in Cognitive Neuroscience. Recurrent topics in Louis Verret's work include Dementia and Cognitive Impairment Research (21 papers), Alzheimer's disease research and treatments (12 papers) and Neurobiology of Language and Bilingualism (8 papers). Louis Verret is often cited by papers focused on Dementia and Cognitive Impairment Research (21 papers), Alzheimer's disease research and treatments (12 papers) and Neurobiology of Language and Bilingualism (8 papers). Louis Verret collaborates with scholars based in Canada, Netherlands and Australia. Louis Verret's co-authors include Rémi W. Bouchard, Robert Laforce, Stéphane Poulin, David Bergeron, Howard Chertkow, Serge Gauthier, Christian Bocti, Ziad Nasreddine, Tamàs Fülöp and Guy Lacombe and has published in prestigious journals such as Neurology, Journal of the American Geriatrics Society and Journal of Cognitive Neuroscience.

In The Last Decade

Louis Verret

25 papers receiving 406 citations

Peers

Countries citing papers authored by Louis Verret

Since Specialization

Citations

This map shows the geographic impact of Louis Verret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Verret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Verret more than expected).

Fields of papers citing papers by Louis Verret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Verret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Verret. The network helps show where Louis Verret may publish in the future.

Co-authorship network of co-authors of Louis Verret

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Verret. A scholar is included among the top collaborators of Louis Verret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Verret. Louis Verret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health System Change for Alzheimer’s Disease-Modifying Therapies in Canada: Beginning the Discussion 2023 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Andrew Frank, Zahinoor Ismail, (unknown), Serge Gauthier, Louis Verret, Ging‐Yuek Robin Hsiung, Michael Borrie	3
2	A Model Predicting Healthcare Capacity Gaps For Alzheimer’s Disease-Modifying Treatment in Canada 2023 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Sandra E. Black, (unknown), Haakon B. Nygaard, Louis Verret, (unknown), (unknown), (unknown)	2
3	Use of Alzheimer’s Disease Cerebrospinal Fluid Biomarkers in A Tertiary Care Memory Clinic 2021 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·(unknown), David Bergeron, (unknown), (unknown), (unknown), (unknown), Leila Sellami, (unknown), (unknown), (unknown), (unknown), Stéphane Poulin, Louis Verret, Rémi W. Bouchard, Charlotte E. Teunissen, Robert Laforce	8
4	Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab 2021 ·Canadian Geriatrics Journal ·Howard Chertkow, Kenneth Rockwood, David B. Hogan, (unknown), Manuel Montero‐Odasso, Shabbir Amanullah, Sandra E. Black, Christian Bocti, Michael Borrie, Howard Feldman, Morris Freedman, Ging‐Yuek Robin Hsiung, Andrew Kirk, Mario Masellis, Haakon B. Nygaard, Tarek K. Rajji, Louis Verret	10
5	Cognitive Profile of the Logopenic Variant of Primary Progressive Aphasia Using the <b><i>Dépistage Cognitif de Québec</i></b> 2020 ·Dementia and Geriatric Cognitive Disorders ·(unknown), (unknown), David Bergeron, Leila Sellami, Louis Verret, (unknown), Stéphane Poulin, Joël Macoir, Carol Hudon, Rémi W. Bouchard, Monica Lavoie, Robert Laforce	5
6	The Behavioral/Dysexecutive Variant of Alzheimer’s Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization 2020 ·Dementia and Geriatric Cognitive Disorders ·David Bergeron, Leila Sellami, Stéphane Poulin, Louis Verret, Rémi W. Bouchard, Robert Laforce	21
7	Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer’s Disease 2020 ·Journal of Alzheimer s Disease ·David Bergeron, Jean‐Mathieu Beauregard, (unknown), Jean‐Paul Soucy, Louis Verret, Stéphane Poulin, Jordi A. Matías‐Guiu, María Nieves Cabrera‐Martín, Rémi W. Bouchard, Robert Laforce	11
8	Validation of the Dépistage Cognitif de Québec in the Oldest Old 2020 ·Canadian Geriatrics Journal ·(unknown), Carol Hudon, (unknown), Leila Sellami, David Bergeron, (unknown), Louis Verret, (unknown), Stéphane Poulin, Joël Macoir, Rémi W. Bouchard, Robert Laforce	2
9	The Dépistage Cognitif de Québec: A New Clinician’s Tool for Early Recognition of Atypical Dementia 2018 ·Dementia and Geriatric Cognitive Disorders ·Leila Sellami, (unknown), (unknown), David Bergeron, Louis Verret, Stéphane Poulin, Léonie Jean, (unknown), (unknown), (unknown), (unknown), Joël Macoir, Carol Hudon, Rémi W. Bouchard, Robert Laforce	9
10	L’apport critique de l’évaluation de la communication dans le diagnostic précoce de l’apraxie primaire progressive de la parole 2017 ·Canadian Journal on Aging / La Revue canadienne du vieillissement ·(unknown), Laura Monetta, Robert Laforce, Louis Verret, Vincent Martel‐Sauvageau	3
11	Multicenter Validation of an MMSE ‐Mo CA Conversion Table 2017 ·Journal of the American Geriatrics Society ·David Bergeron, (unknown), Louis Verret, Stéphane Poulin, Rémi W. Bouchard, Christian Bocti, Tamàs Fülöp, Guy Lacombe, Serge Gauthier, Ziad Nasreddine, Robert Laforce	107
12	Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers 2016 ·Journal of Alzheimer s Disease ·(unknown), Jean‐Mathieu Beauregard, Stéphane Poulin, François-Alexandre Buteau, Jean Guimond, David Bergeron, Louis Verret, (unknown), (unknown), Rémi W. Bouchard, Jean‐Paul Soucy, Robert Laforce	40
13	When the left brain's away, the right will play – Emergent artistic proficiency in primary progressive apraxia of speech 2015 ·Cortex ·David Bergeron, Louis Verret, Olivier Potvin, Simon Duchesne, Robert Laforce	2
14	P2‐197: Dépistage cognitif de québec (DCQ): A novel cognitive screening test for atypical dementias 2015 ·Alzheimer s & Dementia ·David Bergeron, (unknown), (unknown), Stéphane Poulin, Martin Roy, Louis Verret, Rémi W. Bouchard, Robert Laforce	2
15	Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes 2015 ·Journal of Alzheimer s Disease ·David Bergeron, Jean‐Mathieu Beauregard, Jean Guimond, (unknown), (unknown), Stéphane Poulin, Louis Verret, Rémi W. Bouchard, Robert Laforce	10
16	P4–103: Months backward test as a reliable predictor of cognitive decline in mild Alzheimer's disease 2013 ·Alzheimer s & Dementia ·(unknown), Martin Roy, (unknown), Robert Laforce, Louis Verret, (unknown), (unknown), Stéphane Poulin	5
17	The Relation Between Depressive Symptoms and Semantic Memory in Amnestic Mild Cognitive Impairment and in Late-Life Depression 2011 ·Journal of the International Neuropsychological Society ·Julie Brunet, Carol Hudon, Joël Macoir, Sylvie Belleville, François Rousseau, Rémi W. Bouchard, Louis Verret, Howard Chertkow, Céline Chayer, Marie‐Jeanne Kergoat, Sven Joubert	26
18	The Value of PET in Mild Cognitive Impairment, Typical and Atypical/Unclear Dementias: A Retrospective Memory Clinic Study 2010 ·American Journal of Alzheimer s Disease & Other Dementias® ·Robert Laforce, James P Buteau, Nancy Paquet, Louis Verret, (unknown), Rémi W. Bouchard	43
19	Cognitive estimation impairment in Alzheimer disease and mild cognitive impairment. 2006 ·Neuropsychology ·Elise J. Levinoff, Natalie A. Phillips, Louis Verret, (unknown), (unknown), (unknown), Howard Chertkow	35
20	Common and Contrasting Areas of Activation for Abstract and Concrete Concepts: An H215O PET Study 2004 ·Journal of Cognitive Neuroscience ·Christine Whatmough, Louis Verret, (unknown), Howard Chertkow	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact